COMMUNIQUÉS West-GlobeNewswire
-
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
10/09/2024 - 22:30 -
ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference
10/09/2024 - 22:30 -
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/09/2024 - 22:40 -
BridgeBio Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program
10/09/2024 - 22:45 -
BridgeBio Pharma Reports Topline Results from Phase 1/2 Trial of Investigational Gene Therapy for Congenital Adrenal Hyperplasia (CAH)
10/09/2024 - 22:45 -
Creyon Bio Appoints Venture Capitalists Serge Messerlian and Shaquille Vayda to Board of Directors
09/09/2024 - 14:00 -
Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies
09/09/2024 - 14:01 -
Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
09/09/2024 - 14:05 -
Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th
09/09/2024 - 14:15 -
Cassava Sciences Names Rick Barry as Chief Executive Officer
09/09/2024 - 14:30 -
Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year
09/09/2024 - 14:30 -
Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
09/09/2024 - 14:30 -
September 2024 Letter to Shareholders
09/09/2024 - 14:30 -
Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
09/09/2024 - 14:30 -
Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO
09/09/2024 - 14:30 -
Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA
09/09/2024 - 14:30 -
Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference
09/09/2024 - 14:30 -
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
09/09/2024 - 14:30 -
Stereotaxis to Present at Upcoming Investor Conferences
09/09/2024 - 14:40
Pages